Trial Outcomes & Findings for Shared Decision Making in the Emergency Department: Chest Pain Choice Trial (NCT NCT01969240)
NCT ID: NCT01969240
Last Updated: 2018-08-06
Results Overview
Patient knowledge was measured by immediate post-visit survey that included 8 questions about the patient's risk for acute coronary syndrome and the available management options.
COMPLETED
NA
898 participants
Directly following intervention (on day 1)
2018-08-06
Participant Flow
Participant milestones
| Measure |
Chest Pain Choice Decision Aid
Patients randomized to the decision aid arm
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Overall Study
STARTED
|
451
|
447
|
|
Overall Study
COMPLETED
|
451
|
447
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Shared Decision Making in the Emergency Department: Chest Pain Choice Trial
Baseline characteristics by cohort
| Measure |
Chest Pain Choice Decision Aid
n=451 Participants
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 Participants
Patients randomized to the usual care arm (no decision aid used)
|
Total
n=898 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
50.0 years
STANDARD_DEVIATION 15.0 • n=5 Participants
|
50.6 years
STANDARD_DEVIATION 14.1 • n=7 Participants
|
50.3 years
STANDARD_DEVIATION 14.6 • n=5 Participants
|
|
Sex: Female, Male
Female
|
274 Participants
n=5 Participants
|
260 Participants
n=7 Participants
|
534 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
177 Participants
n=5 Participants
|
187 Participants
n=7 Participants
|
364 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
4 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
6 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
155 Participants
n=5 Participants
|
154 Participants
n=7 Participants
|
309 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
262 Participants
n=5 Participants
|
269 Participants
n=7 Participants
|
531 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
22 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
33 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
451 participants
n=5 Participants
|
447 participants
n=7 Participants
|
898 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Directly following intervention (on day 1)Patient knowledge was measured by immediate post-visit survey that included 8 questions about the patient's risk for acute coronary syndrome and the available management options.
Outcome measures
| Measure |
Chest Pain Choice Decision Aid
n=451 Participants
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 Participants
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Test if Chest Pain Choice Safely Improves Patient Knowledge.
|
4.2 number of questions correct
Standard Deviation 1.5
|
3.6 number of questions correct
Standard Deviation 1.5
|
SECONDARY outcome
Timeframe: Within 30 days of study enrollmentWe will measure the effect of the decision aid on the frequency of hospital admission and cardiac testing within 30 days of enrollment.
Outcome measures
| Measure |
Chest Pain Choice Decision Aid
n=451 Participants
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 Participants
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Test if the Decision Aid Has an Effect on Healthcare Utilization Within 30 Days After Enrollment.
Admitted to the hospital
|
22 participants
|
22 participants
|
|
Test if the Decision Aid Has an Effect on Healthcare Utilization Within 30 Days After Enrollment.
Cardiac stress testing
|
172 participants
|
204 participants
|
SECONDARY outcome
Timeframe: Immediately after the intervention (on day 1)1\) Patient engagement in the decision-making process as measured by the OPTION scale. The OPTION scale is composed of 12 items with a value of 0-4; they are summed, divided by 48, and then multiplied by 100. Scores range from 0-100, where higher scores are reflective of higher levels of patient engagement.
Outcome measures
| Measure |
Chest Pain Choice Decision Aid
n=451 Participants
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 Participants
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Test if the Decision Aid Safely Improves Patient Engagement.
|
18.3 units on a scale
Standard Deviation 9.4
|
7.9 units on a scale
Standard Deviation 5.4
|
SECONDARY outcome
Timeframe: within 30 days of enrollmentA MACE was defined as acute myocardial infarction, death due to a cardiac or unknown cause, emergency revascularization, ventricular arrhythmia, or cardiogenic shock.
Outcome measures
| Measure |
Chest Pain Choice Decision Aid
n=451 Participants
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 Participants
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Major Adverse Cardiac Event (MACE)
|
1 participants
|
0 participants
|
SECONDARY outcome
Timeframe: 45 daysIn addition to measuring the effect of the decision aid on the frequency of hospital admission and cardiac testing within 30 days, we measured the total number of tests of any type within 45 days. Although we pre-specified 30-day healthcare utilization, on further discussion among the investigative team the consensus was that we collected utilization data out to 45 days and reporting testing utilization at 45 days will provide more robust results.
Outcome measures
| Measure |
Chest Pain Choice Decision Aid
n=451 Participants
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 Participants
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Total Testing Within 45 Days (a Component of Healthcare Utilization)
|
13.3 number of tests obtained
Standard Deviation 6.9
|
14.7 number of tests obtained
Standard Deviation 7.7
|
SECONDARY outcome
Timeframe: Immediately after the visit (day 1)Decisional conflict, which represents the degree of uncertainty patients experience related to feeling uninformed about the management options, is measured by the decisional conflict scale. The decisional conflict scale includes 16 items that are scored from 0-4; the items are summed, divided by 16, and then multiplied by 25. The scale is from 0-100, where higher scores are reflective of increased patient uncertainty about the choice.
Outcome measures
| Measure |
Chest Pain Choice Decision Aid
n=451 Participants
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 Participants
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Decisional Conflict
|
43.5 units on a scale
Standard Deviation 15.3
|
46.4 units on a scale
Standard Deviation 14.8
|
SECONDARY outcome
Timeframe: Immediately after the visit (day 1)The trust in physician scale consists of 9 items scored from 1-5; the items are subtracted by 1, summed, divided by 9, and then multiplied by 25. The scale ranges from 0-100, where higher values are reflective of higher levels of patient trust in their physician.
Outcome measures
| Measure |
Chest Pain Choice Decision Aid
n=451 Participants
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 Participants
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Physician Trust
|
89.5 units on a scale
Standard Deviation 13.4
|
87.7 units on a scale
Standard Deviation 16.0
|
Adverse Events
Chest Pain Choice Decision Aid
Usual Care
Serious adverse events
| Measure |
Chest Pain Choice Decision Aid
n=451 participants at risk
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 participants at risk
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Cardiac disorders
Major adverse cardiac event
|
0.22%
1/451 • Number of events 1 • 30 days
|
0.00%
0/447 • 30 days
|
Other adverse events
| Measure |
Chest Pain Choice Decision Aid
n=451 participants at risk
Patients randomized to the decision aid arm.
Chest Pain Choice Decision Aid: The clinician will review the decision aid with the patient. The decision aid will be used as a tool to facilitate discussion and educate the patient regarding the rationale for their evaluation up to that point in the ED visit and their individual risk for a heart attack or pre-heart attack. The clinician will provide the patient with management options consistent with both the patient's values and preferences and the clinician's level of comfort.
|
Usual Care
n=447 participants at risk
Patients randomized to the usual care arm (no decision aid used)
|
|---|---|---|
|
Cardiac disorders
Acute myocardial infarction
|
0.89%
4/451 • Number of events 4 • 30 days
|
0.22%
1/447 • Number of events 1 • 30 days
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place